Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
about
Use of corticosteroids during pregnancy and risk of asthma in offspring: a nationwide Danish cohort study.Recommendation for optimal management of severe refractory asthma.Budesonide/formoterol in the treatment of asthma.Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice.
P2860
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@ast
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@en
type
label
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@ast
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@en
prefLabel
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@ast
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@en
P1476
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
@en
P2093
Anne E Tattersfield
P304
P356
10.1016/J.IAC.2005.05.002
P577
2005-08-01T00:00:00Z